Nathalie Bonnin

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Olivier Trédan, Qing Wang, Daniel Pissaloux et al. · Annals of Oncology · 2019 · 191 citations

Medicine, Molecular Medicine, Oncology +16

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study

Olivier Trédan, Isabelle Treilleux, Qing Wang et al. · Targeted Oncology · 2012 · 46 citations

Medicine, Gynecology, Oncology +10

<i>MiR-422a</i> promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma

Nathalie Bonnin, Emma Armandy, Julien Carras et al. · Oncotarget · 2016 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +10

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Nicholas C. Turner, Cristina Saura, Philippe Aftimos et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17